Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
Use this OCUL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OCUL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OCUL SEC filings page. Lician reads the product cache first so this HTML stays unique to Ocular Therapeutix Inc even when a live quote feed is slow.
Latest cached year on this hub. Full OCUL income, balance, and cash tables.